Newsletter
Ellen James Shares Insights From the World's First DMT Clinical Trial

HIT Like a Girl

Ellen James Shares Insights From the World's First DMT Clinical Trial

DMT, a naturally occurring psychedelic tryptamine, may offer rapid-acting and long-lasting antidepressant effects
April 25, 2022

Ellen James Shares Insights From the World's First DMT Clinical Trial

In this episode, Joy sits down with Ellen James, Director of Research and Development at Small Pharma, a neuro-pharmaceutical company that is currently developing a psychedelic-assisted therapy for the treatment of mental health conditions.

Small Pharma is one of the few psychedelic companies working with DMT, a naturally occurring psychedelic tryptamine found in plants and the brain of mammals. Scientific evidence suggests DMT offers the potential for rapid-acting and long-lasting antidepressant effects. Small Pharma is leading the world’s first DMT clinical trial and Ellen tells us all about it!

You may also like

Subscribe to #HPN and never miss new Episodes!

Join Our Newsletter

Proudly supported by:

cover
Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.